| Indy 500-Themed Billboard in Times Square |
| Friday, 18 May 2012 05:26 |
 Novo Nordisk, a world leader in diabetes care, announced today that it has expanded its motorsports initiatives to include an official partnership with INDYCAR. This makes the healthcare company the official diabetes care sponsor of the IZOD IndyCar Series. Novo Nordisk has commissioned a digital billboard in Times Square at the landmark One Times Square building and features its insulin delivery system NovoLog FlexPen (insulin aspart [rDNA origin] injection) and the 27-year-old driver. Novo Nordisk entered the sport in 2009 as the primary sponsor of Charlie Kimball in Firestone Indy Lights, and then advanced to the IZOD IndyCar Series with Chip Ganassi Racing in 2011, where Kimball became the first licensed INDYCAR driver with diabetes to finish the Indianapolis 500. For more Times Square articles like Indy 500-Themed Billboard in Times Square, please visit the Times Square News Section of TimesSquare.com |
